How to Get Medical Cannabis in Italy?
Medical cannabis is legal in Italy since 2007. Patients need a specialist prescription and can obtain cannabis through hospital pharmacies. Regional differences are significant — some regions fully cover costs while others provide limited access.
Detailed Answer
Italy's medical cannabis program is one of the oldest in Europe but remains fragmented due to the country's regional healthcare structure. Cannabis was approved for medical use in 2007, and since 2015, the Military Chemical-Pharmaceutical Factory in Florence (Stabilimento Chimico Farmaceutico Militare) has produced cannabis under the FM2 brand, containing approximately 5-8% THC and 7.5-12% CBD.
To access medical cannabis, patients need a prescription from a specialist doctor (not a general practitioner in most regions). Qualifying conditions typically include chronic pain unresponsive to conventional treatments, multiple sclerosis spasticity, nausea and vomiting from chemotherapy, appetite stimulation in cancer or AIDS patients, glaucoma, and Tourette syndrome. The prescription is then filled at a hospital pharmacy, as standard retail pharmacies generally do not stock medical cannabis.
The major challenge in Italy is regional variation. Each of Italy's 20 regions implements the medical cannabis program differently. Regions like Tuscany, Emilia-Romagna, and Puglia have been relatively progressive, offering broader access and cost coverage through the regional health service. Other regions have more restrictive access or longer wait times. Patients sometimes travel to other regions to fill prescriptions, and supply shortages have been a recurring problem.
Domestic production has been insufficient to meet demand, leading Italy to import medical cannabis from the Netherlands (Bedrocan products), Canada, and other countries. The government has periodically announced plans to increase domestic production capacity and standardize access across regions. As of early 2026, the system remains a patchwork, and patient advocacy groups continue to push for nationwide uniform access and clearer guidelines.